STRONG-UR recently took part in the NEOLIVER workshop, organised by AMIRES, which brought together several EU-funded initiatives working on bioprinting and regenerative medicine.
Three takeaways emerged from the workshop:
- The importance of integrating patients’ perspectives throughout all phases of a project.
- The value of early dialogue between researchers, clinicians and regulatory bodies to support translation.
- The growing role of harmonised standards in facilitating the clinical adoption of bioprinting technologies.


